Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study.

Overview

authors

Levine, Jasmine

Lipner, Shari
Ungar, Benjamin

publication date

June 25, 2025

published in

Allergy Journal

Identity

Digital Object Identifier (DOI)

10.1111/all.16637

PubMed ID

40560741